Vivesto
0.284
SEK
-0.7 %
VIVE
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
2 following
-0.7%
+2.9%
+7.17%
-1.22%
-2.07%
-30.31%
+47.76%
-88.03%
-91.07%
-98.43%
www.vivesto.com/en
Vivesto is a research company. The company specializes in the research and development of drugs for serious diseases in oncology. The technology is based on the company's technical platform where research is based on nanotechnology. Today, operations are conducted mainly in the Nordic countries and North America. The company was founded in 1999 and has its headquarters in Uppsala.
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
NASDAQ Stockholm
VIVE
Daily low / high price
0.277 / 0.286
SEK
Market cap
152.8M SEK
Turnover
26.85K SEK
Volume
95K
Latest videos
Financial calendar
Interim report
2024-11-21
Annual report
2025-02-20
Major OwnersSource: Millistream Market Data AB
| Owner | Capital | Votes |
|---|---|---|
| Per Arwidsson med bolag | 24.8 % | 24.8 % |
| Avanza Pension | 5.8 % | 5.8 % |
| Ilija Batljan | 1.8 % | 1.8 % |
| Johan Zetterstedt | 1.5 % | 1.5 % |
| Swedbank Försäkring | 1.5 % | 1.5 % |
| Nordnet Pensionsförsäkring AB | 1.1 % | 1.1 % |
| Mastan AB (Håkan Lagerberg) | 1.0 % | 1.0 % |
| Jerry Wiström | 0.9 % | 0.9 % |
| Philip Du Rietz | 0.9 % | 0.9 % |
| Christer Ericson | 0.7 % | 0.7 % |
ShowingAll content types
Vivestos Paccal Vet får Limited Market-klassificering i EU
Vivesto’s Paccal Vet receives Limited Market classification in EU
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools